Pharmaceutical: Clomiphene Citrate (36C77024Q0063)
Waiver type - Procurement: Nonavailability
Agency: VETERANS AFFAIRS, DEPARTMENT OF (3600) • Product Service Code (PSC) : 6505 | Last Modified: 12/13/2024
Procurement Summary
VHA Regional Procurement Office Central intends to procure the pharmaceutical Clomiphene Citrate. The pharmaceutical is to be used by the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) to fulfill prescriptions. Based on market research, no domestic sources are available and the pharmaceutical is manufactured in India. Clomiphene Citrate is used for the treatment of ovulatory disfunction, and the pharmaceutical is supplied by the VA CMOP via direct mail order pharmacy services to a Veteran or beneficiary’s place of residence. The Leavenworth CMOP has critically low stock and requires these pharmaceuticals to fulfill veteran prescriptions in support of their medical needs.
Waiver Rationale Summary
Although the Buy American Act is applicable to small business set-asides (FAR 25.101(b)), we will be exercising an exception to the Buy American Act (FAR 25.103(b) Nonavailability) by utilizing a foreign manufacturer, as no domestic end products were discovered during market research. If it is discovered during the solicitation phase that acceptable domestic end products are available to fulfill VA’s requirement, they will be evaluated IAW FAR 25.106
Yes
No
Consistent with Policy
DRUGS AND BIOLOGICALS
325412 - Pharmaceutical Preparation Manufacturing
12/10/2024
N/A
Pre-solicitation
Instant Delivery Only
Individual Waiver
VETERANS AFFAIRS, DEPARTMENT OF